Domov › Disfunkcija levega prekata › New York
Klinične študije za Disfunkcija levega prekata v New York
4 študij za Disfunkcija levega prekata išče udeležence na lokacijah v New York.
Mesta v New York
Uradno besedilo študije (angleško)
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- Columbia University Medical Center-Pediatric Cardiology ( Site 0016), New York
- The Children's Hospital at Montefiore ( Site 0030), The Bronx
Vključevanje udeležencevFaza 2/3
29 Days – 17 Years · Vsi spoli · Posodobljeno 28. avg. 2026 · NCT05714085A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
- Icahn School of Medicine at Mount Sinai - Pediatric Cardiology, New York
- Columbia University Irving Medical Center - Pediatric Cardiology, New York
- The Children's Hospital at Montefiore - Cardiology, The Bronx
Vključevanje udeležencevFaza 3
Do 18 let · Vsi spoli · Posodobljeno 29. jun. 2026 · NCT07192952A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
- Icahn School of Medicine at Mount Sinai - Pediatric Cardiology, New York
- Columbia University Irving Medical Center - Pediatric Cardiology, New York
- The Children's Hospital at Montefiore - Cardiology, The Bronx
Vključevanje udeležencevFaza 3
6 Months – 17 Years · Vsi spoli · Posodobljeno 15. jun. 2026 · NCT07188805AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
- Mount Sinai Hospital, New York
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 18 in več · Vsi spoli · Posodobljeno 1. jun. 2026 · NCT06699056Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.